Suven Pharmaceuticals Limited (SUVENPHAR) — Capital Reinvestment Ratio
Suven Pharmaceuticals Limited (SUVENPHAR) has a Capital Reinvestment Ratio of 0.24x as of September 2020, meaning it reinvests 0% of its operating cash flow (Rs1.04 Billion) in capital expenditures (Rs248.54 Million). See Suven Pharmaceuticals Limited (SUVENPHAR) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Suven Pharmaceuticals Limited Capital Reinvestment Ratio (2019–2025)
This chart tracks Suven Pharmaceuticals Limited's Capital Reinvestment Ratio across 7 annual periods. Check how aggressively does Suven Pharmaceuticals Limited reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year Capital Reinvestment Ratio for Suven Pharmaceuticals Limited from 2019 to 2025. For live market cap and broader valuation context, see market cap of Suven Pharmaceuticals Limited.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.54x | Rs2.88 Billion | Rs1.56 Billion | ▲ +274.1% |
| 2024 | 0.14x | Rs3.58 Billion | Rs517.87 Million | ▼ -77.2% |
| 2023 | 0.63x | Rs4.51 Billion | Rs2.86 Billion | ▲ +178.2% |
| 2022 | 0.23x | Rs3.30 Billion | Rs751.87 Million | ▼ -21.2% |
| 2021 | 0.29x | Rs3.83 Billion | Rs1.11 Billion | ▲ +21.0% |
| 2020 | 0.24x | Rs4.16 Billion | Rs994.15 Million | ▼ -78.8% |
| 2019 | 1.13x | Rs504.05 Million | Rs567.86 Million | — |